About Enhancer

Enhancer ID: E_02_0492
Species: human
Position : chr14:100776351-100778351
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: Type 2 diabetes mellitus (t2dm)
Pubmed ID:  30084829
Enhancer experiment: ChIP-PCR,4C-Seq,RT-PCR
Enhancer experiment description: In this study, using targeted epigenetic modifiers, we prove that increased methylation at the promoter of Meg3 in mouse ?TC6 ?-cells results in decreased transcription of the maternal transcripts associated with this locus. Using circular chromosome conformation capture followed by high-throughput sequencing, we demonstrate that the promoter of MEG3 physically interacts with this novel enhancer and other putative regulatory elements in this imprinted region in human islets. Remarkably, this enhancer is bound in an allele-specific manner by the transcription factors FOXA2, PDX1, and NKX2.2.

About Target gene

Target gene : MEG3(2900016C05Rik,3110050O07Rik,6330408G06Rik,AI425946,AW108224,D12Bwg1266e,Gtl2,R74756,R75394),FOXA2,PDX1(IDX-1,IPF-1,Ipf1,Mody4,STF-1,pdx-1)
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: In this study, using targeted epigenetic modifiers, we prove that increased methylation at the promoter of Meg3 in mouse ?TC6 ?-cells results in decreased transcription of the maternal transcripts associated with this locus. Using circular chromosome conformation capture followed by high-throughput sequencing, we demonstrate that the promoter of MEG3 physically interacts with this novel enhancer and other putative regulatory elements in this imprinted region in human islets. Remarkably, this enhancer is bound in an allele-specific manner by the transcription factors FOXA2, PDX1, and NKX2.2. ;In this study, using targeted epigenetic modifiers, we prove that increased methylation at the promoter of Meg3 in mouse ?TC6 ?-cells results in decreased transcription of the maternal transcripts associated with this locus. Using circular chromosome conformation capture followed by high-throughput sequencing, we demonstrate that the promoter of MEG3 physically interacts with this novel enhancer and other putative regulatory elements in this imprinted region in human islets. Remarkably, this enhancer is bound in an allele-specific manner by the transcription factors FOXA2, PDX1, and NKX2.2. ;In this study, using targeted epigenetic modifiers, we prove that increased methylation at the promoter of Meg3 in mouse ?TC6 ?-cells results in decreased transcription of the maternal transcripts associated with this locus. Using circular chromosome conformation capture followed by high-throughput sequencing, we demonstrate that the promoter of MEG3 physically interacts with this novel enhancer and other putative regulatory elements in this imprinted region in human islets. Remarkably, this enhancer is bound in an allele-specific manner by the transcription factors FOXA2, PDX1, and NKX2.2.

About TF

TF name : --
TF experiment: ChIP-PCR,4C-Seq,RT-PCR
TF experiment description: In this study, using targeted epigenetic modifiers, we prove that increased methylation at the promoter of Meg3 in mouse ?TC6 ?-cells results in decreased transcription of the maternal transcripts associated with this locus. Using circular chromosome conformation capture followed by high-throughput sequencing, we demonstrate that the promoter of MEG3 physically interacts with this novel enhancer and other putative regulatory elements in this imprinted region in human islets. Remarkably, this enhancer is bound in an allele-specific manner by the transcription factors FOXA2, PDX1, and NKX2.2. ;In this study, using targeted epigenetic modifiers, we prove that increased methylation at the promoter of Meg3 in mouse ?TC6 ?-cells results in decreased transcription of the maternal transcripts associated with this locus. Using circular chromosome conformation capture followed by high-throughput sequencing, we demonstrate that the promoter of MEG3 physically interacts with this novel enhancer and other putative regulatory elements in this imprinted region in human islets. Remarkably, this enhancer is bound in an allele-specific manner by the transcription factors FOXA2, PDX1, and NKX2.2. ;In this study, using targeted epigenetic modifiers, we prove that increased methylation at the promoter of Meg3 in mouse ?TC6 ?-cells results in decreased transcription of the maternal transcripts associated with this locus. Using circular chromosome conformation capture followed by high-throughput sequencing, we demonstrate that the promoter of MEG3 physically interacts with this novel enhancer and other putative regulatory elements in this imprinted region in human islets. Remarkably, this enhancer is bound in an allele-specific manner by the transcription factors FOXA2, PDX1, and NKX2.2.

About Function

Enhancer function : In this study, using targeted epigenetic modifiers, we prove that increased methylation at the promoter of Meg3 in mouse ?TC6 ?-cells results in decreased transcription of the maternal transcripts associated with this locus. Using circular chromosome conformation capture followed by high-throughput sequencing, we demonstrate that the promoter of MEG3 physically interacts with this novel enhancer and other putative regulatory elements in this imprinted region in human islets. Remarkably, this enhancer is bound in an allele-specific manner by the transcription factors FOXA2, PDX1, and NKX2.2.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
In this study, using targeted epigenetic modifiers, we prove that increased methylation at the promoter of Meg3 in mouse ?TC6 ?-cells results in decreased transcription of the maternal transcripts associated with this locus. Using circular chromosome conformation capture followed by high-throughput sequencing, we demonstrate that the promoter of MEG3 physically interacts with this novel enhancer and other putative regulatory elements in this imprinted region in human islets. Remarkably, this enhancer is bound in an allele-specific manner by the transcription factors FOXA2, PDX1, and NKX2.2.

About SNP

SNP ID: rs3783355

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs